Llorens Josep's Form 4 filing
Haemonetics Corp (HAE) · filed May 17, 2024
- Accession no.
- 0001127602-24-015868
- Filed
- May 17, 2024
- Trade date
- May 15-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $74.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Llorens JosepCIK 0001750812 | Officer (EVP, Global Manufacturing) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Common Stock | FTax withholdingDisposed | −258 | $96.49 | −$24,894.42 | 18,205 | Direct | |
| May 16, 2024 | Common Stock | FTax withholdingDisposed | −263 | $94.80 | −$24,932.4 | 17,942 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −770 | $96.14 | −$74,027.8 | 17,172 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.